Interaction analysis of statistically enriched mutations identified in Cameroon recombinant subtype CRF02_AG that can influence the development of Dolutegravir drug resistance mutations

BACKGROUND: The Integrase (IN) strand transfer inhibitor (INSTI), Dolutegravir (DTG), has been given the green light to form part of first-line combination antiretroviral therapy (cART) by the World Health Organization (WHO). DTG containing regimens have shown a high genetic barrier against HIV-1 is...

Descripción completa

Detalles Bibliográficos
Autores principales: Mikasi, Sello Given, Isaacs, Darren, Chitongo, Rumbidzai, Ikomey, George Mondide, Jacobs, Graeme Brendon, Cloete, Ruben
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8063366/
https://www.ncbi.nlm.nih.gov/pubmed/33892628
http://dx.doi.org/10.1186/s12879-021-06059-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8063366/
https://www.ncbi.nlm.nih.gov/pubmed/33892628
http://dx.doi.org/10.1186/s12879-021-06059-x

Ejemplares similares